FABP4
Reaktivität: Human
WB, ELISA, IHC (p), IF
Wirt: Maus
Monoclonal
3G1
unconjugated
Applikationshinweise
ELISA: 1:10,000, WB: 1:500-1:2000 Optimal conditions should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
Lot specific
Buffer
Supplied as a liquid in ascitic fluid containing 0.03 % sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
Handhabung
Avoid repeated freeze/thaw cycles. Dilute only prior to immediate use.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Store at 4 °C for short term storage. Store at -20 °C for long term storage.
Target
FABP4
(Fatty Acid Binding Protein 4, Adipocyte (FABP4))
Andere Bezeichnung
FABP4
Hintergrund
FABP4 is expressed in adipocytes and macrophages, and integrates inflammatory and metabolic responses. FABP4 is thought to regulate fatty acid uptake, release, and storage in adipocytes and participates in systemic glucose homeostasis and in macrophage responses in atherosclerosis. Blocking this protein either through genetic engineering or drugs has the possibility of treating heart disease, diabetes, asthma, obesity, and fatty liver disease. Synonyms: Monoclonal FABP4 antibody, Anti-FABP4 antibody, Fatty acid binding protein 4 antibody, fatty acid binding protein 4 adipocyte antibody, A-FABP antibody, aP2 antibody.